España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Northwest Biotherapeutics
NWBO
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.2660
0.00590
2.27%
At close: -
Get Report
Comment
Northwest Biotherapeutics (NWBO) Forecast
News
Earnings
Northwest Biotherapeutics (NWBO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Northwest Biotherapeutics (OTC:NWBO) Stock
Northwest Biotherapeutics Stock (OTC: NWBO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, October 18, 2022
Northwest Biotherapeutics Files For Mixed-Securities Shelf Offering Of Up To $250M
Michael Horton
Monday, September 12, 2022
A Quick Look At The OTC Markets' Most-Active Securities In August - Here's What You Need to Know
Jad Malaeb
-
Sponsored
Friday, August 05, 2022
These 2 Under-The-Radar Stocks Traded More Than $1B Each Last Month
Chris Katje
Monday, July 18, 2022
Mortgage Financiers & Crypto Securities Reclaim Their Spots As Most Actively Traded Securities On OTC Markets In June
Jad Malaeb
-
Sponsored
Friday, June 17, 2022
The OTC Markets' Most-Active Securities Embrace International Operators As Volatility Envelops Markets In May
Jad Malaeb
-
Sponsored
Tuesday, May 03, 2022
If You Invested $1000 In Northwest Biotherapeutics 5 Years Ago, Here's How Much You Would Have Today
Benzinga Insights
Tuesday, October 27, 2020
Traders Have Rotated Into Big Multinational Companies On OTC Markets
Spencer Israel
Tuesday, June 16, 2020
Traders Had Cannabis And Transportation Companies On OTC Markets In Focus During May
Spencer Israel
Tuesday, March 24, 2020
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights
Wednesday, May 22, 2019
Trader Idea Feed: 'We took a look at the late...
Benzinga Newsdesk
Thursday, May 31, 2018
'$NWBO granted millions of stock options to insiders the day before DCVax paper published. But sure, keep banging on about naked shorts.'-STAT's Adam Feuerstein Tweets
Benzinga
Friday, April 06, 2018
'$NWBO is seeking to increase authorized comm...
Benzinga
Tuesday, December 19, 2017
Adam Feuerstein Tweets: How desperate is $NWB...
Benzinga
Monday, December 04, 2017
Adam Feuerstein Tweets: Another $NWBO vulture...
Benzinga
Wednesday, September 20, 2017
NW BIO Reports Registered Direct Offering Of ...
Benzinga
Thursday, June 22, 2017
Chardan Capital Is Suing Norhtwest Bio For Breach Of Placement Agency Agreement
Benzinga
Tuesday, April 18, 2017
Adam Feuerstein Tweets: $NWBO Receives SEC Su...
Benzinga
Thursday, December 08, 2016
Northweat Biotherapeutics Offers Update on Ph...
Benzinga
Thursday, November 17, 2016
NW Bio +37.78% @$0.62, Co Announced Phase II ...
Benzinga
Friday, October 21, 2016
Northwest Biotherapeutics Reports Registered ...
Benzinga
Thursday, October 20, 2016
9 Stocks Which Rallied Four Days, Then Sold Off Yesterday
Benzinga
Friday, September 23, 2016
S-3 from Northwest Biotherapeutics Shows Regi...
Benzinga
Tuesday, August 23, 2016
Adam Feuerstein @adamfeuerstein Tweet: $NWBO ...
Benzinga
Thursday, August 11, 2016
TheStreet's Adam Feuerstein Publishes 'Short of Cash, Northwest Bio Flirts With Insolvency'
Benzinga
Thursday, July 28, 2016
NW Biotherapeutics Spikes to High of $0.54 on...
Benzinga
Monday, May 16, 2016
Northwest Biotherapeutics Enters Agreement With Holder to Exercise All of Series B Warrants to Purchase purchase 4,411,764 Shares of Common Stock -8K
Benzinga
Tuesday, May 10, 2016
Northwest Biotherapeutic Files for Non-Timely...
Benzinga
Tuesday, May 03, 2016
TheStreet's Adam Feuerstein Tweets '$MRK $BMY are not working with $NWBO on cancer immunotherapy combination clinical trials, per their respective spokespersons.'
Benzinga
Monday, May 02, 2016
NW Bio Reports Phase I DCVax-Direct Trial Show 20 Of 40 Patients Have Exceeded 12 Months Overall Survival, Says Phase III Trial Of DCVax-L For GBM Brain Cancer Is Ongoing
Benzinga
Monday, February 29, 2016
Northwest Biotherapeutics To Sell 5.88M Share...
Benzinga
NW Bio Shares Sell Off to Low of $1.90 on Off...
Benzinga
Friday, January 08, 2016
NW Bio Issues Statement on Adverse Market Conditions And NW Bio Stock Decline, Sees Global Market Concerns, But Reiterates Encouraging Clinical Data
Benzinga
Wednesday, December 23, 2015
Mid-Afternoon Market Update: Dow Surges Over 1%; Bed Bath & Beyond Shares Slip On Lowered Q3 Outlook
Benzinga
Northwest Biotherapeutics Crashes On 3.5 Million Share Offering
Benzinga
Mid-Day Market Update: Crude Oil Down 4%; Adamas Pharmaceuticals Shares Jump Following Positive Phase 3 Results
Benzinga
Mid-Morning Market Update: Markets Open Higher; Nike Profit Tops Expectations
Benzinga
NW Bio Reports Registration for $12.6M Direct...
Benzinga
Tuesday, December 08, 2015
NW Bio Forms Special Committee To Conduct Indpendent Investigation Of Recent Anonymous Allegations Made Against The Company
Benzinga
NW Bio Establishes Special Committee, Selects Law Firm to Conduct Independent Investigation of Recent Allegations
Benzinga
Monday, November 30, 2015
Early Global News: Clinton's $275 Billion Infrastructure Plan, US Proximity Mobile Payment Transactions to Reach $8.71 Billion And More
Benzinga
UPDATE: Northwest Biotherapeutics Says Co. Bo...
Benzinga
NW Bio Outlines Plans to Expand Board, Says W...
Benzinga
Tuesday, November 24, 2015
Woodford Investment Management Reports 28.1% ...
Benzinga
Friday, November 13, 2015
Northwest Biotherapeutics Files For $150M Mix...
Benzinga
Wednesday, October 21, 2015
NW Bio Enters Into Agreement For $30M Of New Equity Funding From Woodford Investment Management
Benzinga
Monday, October 19, 2015
UPDATE: NW Bio Says Co. 'is intensifying its ...
Benzinga
UPDATE: NW Bio 'believes this activity is par...
Benzinga
NW Bio Says Not Aware of Fundamental Reason for Friday's Decline in Pricr
Benzinga
Northwest Biotherapeutics Says Not Aware of A...
Benzinga
Friday, October 16, 2015
Shares Of Northwest Biotherapeutics Falls To ...
Benzinga
Show More